iFAST Diagnostics
Latest round
- Seed
Last raised
- Sep 2024
Total raised
- $6.7M
Investors
- 7
About iFAST Diagnostics
Based in Hampshire, UK, and founded in 2022, iFAST Diagnostics Limited operates as a provider of rapid antimicrobial susceptibility testing (AST) solutions to healthcare facilities, aiming to prevent antimicrobial resistance by delivering better diagnostic results. Toby King. iFAST Diagnostics specializes in antimicrobial susceptibility testing (AST) with its flagship product, the iFAST demonstrator platform. This advanced technology accelerates the testing process, delivering results in under three hours from a positive blood or raw urine sample. The core functionality involves extracting bacteria from the sample, exposing them to various antibiotics, and then using a high-speed microfluidic chip to measure the electrical properties of individual bacteria. This method allows the iFAST reader to determine the optimum antibiotic for treatment, which can take 48 to 72 hours. The company primarily serves hospitals and healthcare facilities across the United Kingdom and is expanding its reach internationally. iFAST Diagnostics operates on a transaction structure that incorporates direct sales of its testing platforms and associated services to healthcare providers. The pricing for their services is structured at approximately GBP 20 per patient.
Who invested in iFAST Diagnostics
7 investors across 1 round
See all investors in iFAST Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 30, 2024
Amount
$6.7M
Investors
Questions about iFAST Diagnostics
Who invested in iFAST Diagnostics?
iFAST Diagnostics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iFAST Diagnostics raised?
iFAST Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iFAST Diagnostics last raise money?
iFAST Diagnostics's most recent round on record is a Seed, in Sep 2024.
What does iFAST Diagnostics do?
Based in Hampshire, UK, and founded in 2022, iFAST Diagnostics Limited operates as a provider of rapid antimicrobial susceptibility testing (AST) solutions to healthcare facilities, aiming to prevent antimicrobial resistance by delivering better diagnostic results.
Where is iFAST Diagnostics headquartered?
iFAST Diagnostics is headquartered in Hampshire, UK.
Which VCs invest in companies like iFAST Diagnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at iFAST Diagnostics's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like iFAST Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.